Sign in

CIK 0001619856

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Caribou Biosciences, Inc.

Sign in to watch
Ticker
CRBU
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453728228
Phone
+1 510-982-6030
Business address
2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale Chief Medical Officer sold 5,627 shares at $6.31 ($35,506)
  8. 4 Exercise or conversion Chief Scientific Officer acquired 21,401 shares (option exercise)
  9. 4 Open-market sale VP of Finance and Controller sold 10,000 shares at $10.80 ($107,958)
  10. 4 Exercise or conversion Chief Legal Officer acquired 27,595 shares (option exercise)
  11. 4 Open-market sale Chief Scientific Officer sold 43,248 shares at $11.22 ($485,221)
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award VP of Finance and Controller acquired 4,848 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Exercise or conversion Chief Scientific Officer acquired 74,420 shares (option exercise)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Exercise or conversion President and CEO acquired 10,000 shares (option exercise)
  18. 4/A Exercise or conversion President and CEO acquired 10,000 shares (option exercise)
  19. 4 Exercise or conversion VP of Finance and Controller acquired 2,274 shares (option exercise)
  20. 4 Exercise or conversion VP of Finance and Controller acquired 2,274 shares (option exercise)

Page 4 of 7 · 125 filings